AHA Comments to CMS on OPPS Proposed Rule for CY 2018

AHA letter to CMS regarding proposed cuts to the 340B Drug Pricing Program.

Key Resources

Related Resources

Advancing Health Podcast
How Legal Advocacy Is Shaping the Future of Health Care
Public
Guides/Reports
More Drug Company Oversight Needed to Maintain Compliance with 340B Program Rules
Public
Issue Landing Page
The 340B Drug Pricing Program
Public
Letter/Comment
AHA Urges HHS to Reject the Effort by Several Large Drug Companies to Undermine the 340B Drug Pricing Program
Public
Fact Sheets
Fact Sheet: Legislative Proposals Under Consideration Would Jeopardize Access to Care for Patients and Communities
Public
Fact Sheets
Fact Sheet: Estimated Impact of Hospital On-campus and Off-campus Site-Neutral Proposal
Public